Diabetes News

In this episode, host Hansa Bhargava, MD, chats with Sharon Horesh-Bergquist, MD, about chronic disease, screenings and lifestyle and preventive medicine, as well as discussing physician wellness and burnout.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Melanie Betz, MS, RD, CSR, FNKF, FAND, about preventing kidney stones through diet and nutrition.

Maternal and paternal metformin use during conception did not increase the risk for adverse pregnancy outcomes, two studies in Annals of Internal Medicine showed.

Metformin exposure during pregnancy was not associated with adverse childhood neurodevelopmental outcomes up to age 14 years, according to a systematic review and meta-analysis published in the American Journal of Obstetrics and Gynecology.

PHILADELPHIA — Some dietary change may improve cardiometabolic measures beyond weight loss and providers should create a diet that will most benefit each individual with obesity, according to a speaker.

BOSTON — Lowering cardiovascular risk for people with type 2 diabetes requires effort from far beyond the clinician’s office, leveraging creative community partnerships that address social determinants of health, according to a speaker.

The FDA approved the SGLT2 inhibitor dapagliflozin to improve glycemic control among children and adolescents aged 10 years and older with type 2 diabetes, according to an industry press release.

PHILADELPHIA — In this Healio video exclusive, Deepak L. Bhatt, MD, MPH, discusses two hot topics in cardiometabolic medicine: icosapent ethyl and sotagliflozin.

PHILADELPHIA — Adults with Cushing’s syndrome who responded to relacorilant had sustained improvements in blood pressure and glucose levels through 34 weeks, according to findings from a phase 3 trial.

PHILADELPHIA — In patients with acute MI who had successful PCI and underwent imaging to assess plaque composition, diabetes raised risk for poor outcomes but the difference was not related to plaque, according to a presentation.